Tango Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in discovering and delivering precision cancer medicines. It also identifies novel targets and develops new drugs directed at tumor suppressor gene loss in defined patient populations with high unmet medical need. The company was founded by Alan Ashworth, William G. Kaelin Jr., Jose Baselga, and Antoni Ribas in 2017 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
155
Frequently Asked Questions
What is Market Cap of Tango Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Tango Therapeutics Inc market cap is $761.02M.
What is the 52-week high for Tango Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Tango Therapeutics Inc 52 week high is $10.85 as of September 13, 2025.
What is the 52-week low for Tango Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Tango Therapeutics Inc 52 week low is $1.03 as of September 13, 2025.
What is Tango Therapeutics Inc stock price today?
Tango Therapeutics Inc stock price today is $6.53.
What was Tango Therapeutics Inc stock price yesterday?
Tango Therapeutics Inc stock price yesterday was $6.84.
What is the PE ratio of Tango Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Tango Therapeutics Inc’s P/E ratio is -5.15.
What is the Price-to-Book ratio of Tango Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Tango Therapeutics Inc P/B ratio is 5.6194.
What is the 50-day moving average of Tango Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Tango Therapeutics Inc 50-day moving average is $6.56.
How many employess does Tango Therapeutics Inc has?